Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes
NCT04971694 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175
Last updated 2024-11-19
Summary
Assess the impact of steroid, diuretic, and fluid practices on BPD outcomes in extreme premature infants in the Banner - University Medical Center Phoenix (BUMCP) neonatal intensive care unit (NICU).
Conditions
- BPD - Bronchopulmonary Dysplasia
Interventions
- OTHER
-
No interventions or procedures
This is a retrospective observational study and data will be collected from the subject's existing medical record. No interventions or procedures will be required for this study.
Sponsors & Collaborators
-
Banner Health
collaborator OTHER -
Phoenix Children's Hospital
collaborator OTHER -
Pediatrix
lead OTHER
Principal Investigators
-
Alejandra Valladolid, MD · Banner University Medical Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-30
- Primary Completion
- 2022-09-19
- Completion
- 2024-07-06
Countries
- United States
Study Locations
More Related Trials
-
Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia
NCT01644981 ·Status: COMPLETED
-
Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
NCT00067613 ·Status: COMPLETED ·Phase: NA
-
Pragmatic Research on Diuretic Management in Early BPD Pilot
NCT05898022 ·Status: COMPLETED ·Phase: PHASE4
-
Physiologic Definition of Bronchopulmonary Dysplasia
NCT01223287 ·Status: COMPLETED
-
Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia
NCT05055193 ·Status: COMPLETED
-
Analysis of BPD in Premature Infants With Typical Imaging Changes
NCT04163822 ·Status: COMPLETED
-
Duodenal Feeds in Very Low Birth Weight Infants
NCT04246333 ·Status: COMPLETED ·Phase: NA
-
Hydrocortisone for BPD
NCT01353313 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Volatile Organic Compounds (VOCs), Airway Mucins and the Microbiome in the Early Prediction of Bronchopulmonary Dysplasia (BPD)
NCT06342752 ·Status: RECRUITING
-
Corticosteroid Use in Premature Babies and Lung Ultrasonografi Use in the Progression to Bronchopulmonary Dysplasia
NCT05621785 ·Status: UNKNOWN
-
Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project)
NCT00005289 ·Status: COMPLETED
-
L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia
NCT03542812 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Hydrotherapy in Premature Infants With Bronchopulmonary Dysplasia
NCT03538977 ·Status: UNKNOWN ·Phase: NA
-
Lung Ultrasound for Prediction of Bronchopulmonary Dysplasia
NCT04756297 ·Status: COMPLETED
-
Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS
NCT01996670 ·Status: COMPLETED
-
Dexamethasone Regimens for BPD Prevention in Preterm Infants
NCT07052201 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Comparison of Classification Standards of Bronchopulmonary Dysplasia (BPD) in Premature Infants
NCT04184648 ·Status: COMPLETED
-
Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome
NCT04984057 ·Status: UNKNOWN ·Phase: NA
-
Clinical Interventions in Respiratory Distress Syndrome and Neonatal Lung Injury - SCOR in Lung Biology and Diseases in Infants and Children
NCT00005683 ·Status: COMPLETED
-
Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants
NCT00742534 ·Status: WITHDRAWN ·Phase: PHASE1
-
MRI in BPD Subjects
NCT03657693 ·Status: RECRUITING
-
Respiratory Management of Preterm Infants and Bronchopulmonary Dysplasia
NCT03411018 ·Status: COMPLETED
-
Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)
NCT00005777 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Autologous Cord Blood Mononuclear Cells for Treatment of Bronchopulmonary Dysplasia in Extremely Preterm Neonates
NCT05071638 ·Status: UNKNOWN ·Phase: PHASE3
-
Restricted Versus Liberal Fluid Intake for Prevention of Bronchopulmonary Dysplasia
NCT06954142 ·Status: RECRUITING ·Phase: NA